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CATATONIC SYNDROME : TREATMENT 
RESPONSE TO LORAZEPAM 
Sir, 
We read with interest the study by Payee 
et al. (1999). Authors remark that no study on the 
treatment of catatonia with lorazepam has been 
carried out in India. In this context, we would like 
to mention that a similar but more exhaustive 
study has been conducted by us on a larger patient 
population at Central Institute of Psychiatry, 
Ranchi. We share a few findings from our study, 
which is currently in the process of publication. 
Our study had 60 patients who were divided 
into four treatment groups- low dose (4 mg/day) 
and high dose (8 mg/day) oral lorazepam and 
low dose (4 mg/day) and high dose (8 mg/day) 
intravenous lorazepam. Besides using the Bush-
Francis Catatonia Screening Instrument and the 
Bush-Francis Catatonia Rating Scale (BFCRS), 
Brief Psychiatric Rating Scale (BPRS) was also 
used to assess the psychopathology. Some of our 
findings concurred with the findings of the 
aforementioned study. For instance, we found 
more patients with schizophrenia as well as acute 
and transient psychotic disorders than affective 
disorders presenting with catatonic syndrome. 
Moreover, severity and duration of catatonia did 
not predict the response to treatment with 
lorazepam. However, there were other results, 
which were at variance with the authors' study. 
We observed that treatment response after 72 
hours of treatment with lorazepam was the best 
predictor of the final treatment outcome. 
THE EDITOR 
Furthermore, although response to lorazepam did 
not vary significantly across the different 
psychiatric diagnoses, patients with acute and 
transient psychotic disorders did show greater 
improvement. 
A new finding was the positive correlation 
between psychopathology based on BPRS scores 
before treatment and the severity of catatonia. 
However, there was no correlation between BPRS 
scores before treatment and the scores of 
catatonia on BFCRS following treatment. This 
indicated that the severity of psychopathology did 
not have any predictive value in the therapeutic 
response of lorazepam in catatonia. Other novel 
findings not alluded to before in the available 
literature included the faster onset of action of 
intravenous lorazepam in comparison to oral 
lorazepam. There was a significant difference 
between the oral and parenteral groups after half 
an hour of treatment. This may be attributed to 
difference in pharmacokinetics between the two 
routes of lorazepam administration. However, the 
treatment response did not differ between the two 
groups after 96 hours of treatment. Moreover, 
response of catatonic signs to low dose and high 
dose lorazepam did not differ significantly in either 
the oral or the parenteral group. 
Although our study is of open-label design, 
nevertheless it allows a few tentative conclusions. 
First, schizophrenia along with acute and transient 
psychotic disorders remain a dominant cause of 
catatonic syndrome in India, which differs from 
western studies implicating affective disorders as 
the main cause (Rosebush et al., 1990; Bush et 
al.,1996). Second, an initial dramatic 
improvement in catatonic symptomatology on 
parenteral lorazepam has no predictive value in 
ascertaining future response to it. Third, over a 
period of four days, there is no significant 
difference in response of catatonic signs to oral 
or parenteral lorazepam. Finally, no additional 
benefit is accrued by giving higher doses of 
lorazepam in the treatment of catatonic syndrome. 
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PSYCHIATRIC ILLNESS AND THE LUNAR 
SYNODIC CYCLE 
Sir, 
On the basis of the data that they had 
collected, Parmeshwaran et al.(1999) concluded 
that a significant relationship exists between 
phases of the lunar synodic cycle and the 
development of psychiatric morbidity. From a 
methodological perspective, I have a 
reservation about their validity of their 
conclusions : 
Parmeshwaran et al.(1999) studied 
patients at the time of admission and not at the 
time of onset or exacerbation of symptoms. 
Since onset or exacerbation of symptoms is 
likely to precede admission by day to months, 
all that can be concluded from their data is that 
there appears to be an association between 
phases of the moon and the decision to present 
at psychiatric services. Such an association is 
very hard to explain on the basis of geomagnetic 
and other forces. 
From a theoretical perspective, I wish to 
point out that fluctuations in the gravitational 
field of the moon are very small; this is easily 
judged from the fact that the tidal effect is merely 
a few feet in height, on a body of water that is 
up to-6 miles deep. Therefore, the minor 
influence of the moon on biological functions is 
likely to be drowned out by the background noise 
generated by terrestrial biopsychosocial 
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variables or compensated for by 
neuropsychological and neurochemical 
homeostatic mechanisms. 
Finally, the authors use their full moon 
data to hypothesize that solar radition influences 
non-affective psychoses. They state that "the 
new moon must be obstructing a sufficient 
number of these charged particles from reaching 
the earth". This does not make sense because 
the visibility of the moon depends upon light 
reflected from the sun and because the new 
moon and full moon are nocturnal phenomena 
that occur when the sun is shining on the 
opposite side of the earth relative to the 
observer. The issue of the moon blocking solar 
radiation therefore does not arise. 
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GENETIC COUNSELLING IN SCHIZOPHRENIA 
Schizophrenia is a complex trait involving 
an interplay of genetic, environmental agents, 
experiences and chance factors (Rioch & 
Mirekangas, 1996). Enthusiasm for detecting genes 
associated with major mental disorders have been 
fueled by rapid advances in the Human Genome 
Project. Currently, the strongest evidence 
implicates chromosomes 6 and 8 for harbouring 
schizophrenia susceptibility genes (Moldin & 
Gottesman,1997). This progress in the field of 
medical genetics has lead to psychosocial 
implications and ethical dilemmas particularly in 
questions related to reproduction (Gottesman & 
Moldin, 1997). In view of the social stigma attached 
to this psychiatric disorder and the misconceptions 
regarding the risk of recurrence, genetic counselling 
should become an essential part of our psychiatric 
repertoire. However, counselling for schizophrenia 
is particularly difficult. Firstly, the definition of the 
illness often presents problems and there is still a 
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